Cargando…

Biological Safety Studies and Simultaneous Determination of Linagliptin and Synthetic Impurities by LC-PDA

A stability-indicating LC method was developed for quantification of linagliptin (LGT) and three synthetic impurities. The method utilizes a Thermo Scientific® RP-8 column (100 mm × 4.6 mm; 5 μm) with the PDA detector for quantitation of impurities. A mixture of 0.1% formic acid with pH 3.5 (A) and...

Descripción completa

Detalles Bibliográficos
Autores principales: Heleno Ferreira, Raquel Balestri, Duarte, Jonathaline Apollo, Ferreira, Flávio Dias, de Oliveira, Luis Flávio Souza, Machado, Michel Mansur, Malesuik, Marcelo Donadel, Paula, Fávero Reisdorfer, Steppe, Martin, Schapoval, Elfrides Eva Shermann, Paim, Clésio Soldateli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6421826/
https://www.ncbi.nlm.nih.gov/pubmed/30944754
http://dx.doi.org/10.1155/2019/7534609
_version_ 1783404307525140480
author Heleno Ferreira, Raquel Balestri
Duarte, Jonathaline Apollo
Ferreira, Flávio Dias
de Oliveira, Luis Flávio Souza
Machado, Michel Mansur
Malesuik, Marcelo Donadel
Paula, Fávero Reisdorfer
Steppe, Martin
Schapoval, Elfrides Eva Shermann
Paim, Clésio Soldateli
author_facet Heleno Ferreira, Raquel Balestri
Duarte, Jonathaline Apollo
Ferreira, Flávio Dias
de Oliveira, Luis Flávio Souza
Machado, Michel Mansur
Malesuik, Marcelo Donadel
Paula, Fávero Reisdorfer
Steppe, Martin
Schapoval, Elfrides Eva Shermann
Paim, Clésio Soldateli
author_sort Heleno Ferreira, Raquel Balestri
collection PubMed
description A stability-indicating LC method was developed for quantification of linagliptin (LGT) and three synthetic impurities. The method utilizes a Thermo Scientific® RP-8 column (100 mm × 4.6 mm; 5 μm) with the PDA detector for quantitation of impurities. A mixture of 0.1% formic acid with pH 3.5 (A) and acetonitrile (B) was used as the mobile phase at a flow rate of 0.6 mL·min(−1) with gradient elution. The percentage of mobile phase B increases from 30% to 70% over 5 min and decreases from 70% to 30% between 5 and 8 min. The method was validated according to International Council for Harmonization (ICH) guidelines. The LOD values obtained were 0.0171 μg·mL(−1) and 0.015 μg·mL(−1) for LGT and impurities, respectively. The LOQ values were 0.06 μg·mL(−1) for LGT and impurities. In all cases, the correlation coefficients of LGT and impurities were >0.999, showing the linearity of the method. The % recovery of the LGT and added impurity were in the range of 92.92–99.79%. The precision of the method showed values less than 1.47% for LGT and less than 4.63% for impurities. The robustness was also demonstrated by small modifications in the chromatographic conditions. The selectivity was evidenced because the degradation products formed in stress conditions did not interfere in the determination of LGT and impurities. Toxicity prediction studies suggested toxicity potential of the impurities, which was confirmed using biological safety studies in vitro.
format Online
Article
Text
id pubmed-6421826
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-64218262019-04-03 Biological Safety Studies and Simultaneous Determination of Linagliptin and Synthetic Impurities by LC-PDA Heleno Ferreira, Raquel Balestri Duarte, Jonathaline Apollo Ferreira, Flávio Dias de Oliveira, Luis Flávio Souza Machado, Michel Mansur Malesuik, Marcelo Donadel Paula, Fávero Reisdorfer Steppe, Martin Schapoval, Elfrides Eva Shermann Paim, Clésio Soldateli J Anal Methods Chem Research Article A stability-indicating LC method was developed for quantification of linagliptin (LGT) and three synthetic impurities. The method utilizes a Thermo Scientific® RP-8 column (100 mm × 4.6 mm; 5 μm) with the PDA detector for quantitation of impurities. A mixture of 0.1% formic acid with pH 3.5 (A) and acetonitrile (B) was used as the mobile phase at a flow rate of 0.6 mL·min(−1) with gradient elution. The percentage of mobile phase B increases from 30% to 70% over 5 min and decreases from 70% to 30% between 5 and 8 min. The method was validated according to International Council for Harmonization (ICH) guidelines. The LOD values obtained were 0.0171 μg·mL(−1) and 0.015 μg·mL(−1) for LGT and impurities, respectively. The LOQ values were 0.06 μg·mL(−1) for LGT and impurities. In all cases, the correlation coefficients of LGT and impurities were >0.999, showing the linearity of the method. The % recovery of the LGT and added impurity were in the range of 92.92–99.79%. The precision of the method showed values less than 1.47% for LGT and less than 4.63% for impurities. The robustness was also demonstrated by small modifications in the chromatographic conditions. The selectivity was evidenced because the degradation products formed in stress conditions did not interfere in the determination of LGT and impurities. Toxicity prediction studies suggested toxicity potential of the impurities, which was confirmed using biological safety studies in vitro. Hindawi 2019-03-03 /pmc/articles/PMC6421826/ /pubmed/30944754 http://dx.doi.org/10.1155/2019/7534609 Text en Copyright © 2019 Raquel Balestri Heleno Ferreira et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Heleno Ferreira, Raquel Balestri
Duarte, Jonathaline Apollo
Ferreira, Flávio Dias
de Oliveira, Luis Flávio Souza
Machado, Michel Mansur
Malesuik, Marcelo Donadel
Paula, Fávero Reisdorfer
Steppe, Martin
Schapoval, Elfrides Eva Shermann
Paim, Clésio Soldateli
Biological Safety Studies and Simultaneous Determination of Linagliptin and Synthetic Impurities by LC-PDA
title Biological Safety Studies and Simultaneous Determination of Linagliptin and Synthetic Impurities by LC-PDA
title_full Biological Safety Studies and Simultaneous Determination of Linagliptin and Synthetic Impurities by LC-PDA
title_fullStr Biological Safety Studies and Simultaneous Determination of Linagliptin and Synthetic Impurities by LC-PDA
title_full_unstemmed Biological Safety Studies and Simultaneous Determination of Linagliptin and Synthetic Impurities by LC-PDA
title_short Biological Safety Studies and Simultaneous Determination of Linagliptin and Synthetic Impurities by LC-PDA
title_sort biological safety studies and simultaneous determination of linagliptin and synthetic impurities by lc-pda
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6421826/
https://www.ncbi.nlm.nih.gov/pubmed/30944754
http://dx.doi.org/10.1155/2019/7534609
work_keys_str_mv AT helenoferreiraraquelbalestri biologicalsafetystudiesandsimultaneousdeterminationoflinagliptinandsyntheticimpuritiesbylcpda
AT duartejonathalineapollo biologicalsafetystudiesandsimultaneousdeterminationoflinagliptinandsyntheticimpuritiesbylcpda
AT ferreiraflaviodias biologicalsafetystudiesandsimultaneousdeterminationoflinagliptinandsyntheticimpuritiesbylcpda
AT deoliveiraluisflaviosouza biologicalsafetystudiesandsimultaneousdeterminationoflinagliptinandsyntheticimpuritiesbylcpda
AT machadomichelmansur biologicalsafetystudiesandsimultaneousdeterminationoflinagliptinandsyntheticimpuritiesbylcpda
AT malesuikmarcelodonadel biologicalsafetystudiesandsimultaneousdeterminationoflinagliptinandsyntheticimpuritiesbylcpda
AT paulafaveroreisdorfer biologicalsafetystudiesandsimultaneousdeterminationoflinagliptinandsyntheticimpuritiesbylcpda
AT steppemartin biologicalsafetystudiesandsimultaneousdeterminationoflinagliptinandsyntheticimpuritiesbylcpda
AT schapovalelfridesevashermann biologicalsafetystudiesandsimultaneousdeterminationoflinagliptinandsyntheticimpuritiesbylcpda
AT paimclesiosoldateli biologicalsafetystudiesandsimultaneousdeterminationoflinagliptinandsyntheticimpuritiesbylcpda